AstraZeneca PLC (AZN)
89.82
-0.12
(-0.13%)
USD |
NASDAQ |
Jan 21, 10:02
AstraZeneca Free Cash Flow: 9.870B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| GSK Plc | 5.645B |
| Amgen, Inc. | 11.54B |
| Gilead Sciences, Inc. | 9.162B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Sanofi | 9.170B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 5.202B |
| Cash from Investing (Quarterly) | -2.088B |
| Cash from Financing (Quarterly) | -2.058B |
| Free Cash Flow Per Share (Quarterly) | 1.116 |
| Free Cash Flow to Equity (Quarterly) | 3.691B |
| Free Cash Flow to Firm (Quarterly) | 3.821B |
| Free Cash Flow Yield | 3.52% |